Unpatented innovation and merger synergies

被引:3
|
作者
Beneish, M. D. [1 ]
Harvey, C. R. [2 ,3 ]
Tseng, A. [1 ]
Vorst, P. [4 ]
机构
[1] Indiana Univ, Kelley Sch Business, Bloomington, IN 47405 USA
[2] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA
[3] Natl Bur Econ Res, Cambridge, MA 02138 USA
[4] Maastricht Univ, Sch Business & Econ, Maastricht, Netherlands
关键词
Intellectual property; Intangibles; R&D; Technology; Non-patented innovation; Trade secrets; Innovation; Purchase price allocations; Acquisitions; Mergers; Synergies; RESEARCH-AND-DEVELOPMENT; INTELLECTUAL PROPERTY; OPERATING PERFORMANCE; STOCK-MARKET; CREATE VALUE; FIRM SIZE; INFORMATION; RETURNS; PATENT; ACQUISITIONS;
D O I
10.1007/s11142-021-09613-9
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
The increasingly service-based U.S. economy relies on innovation. While there is considerable research on the importance of certain innovative activities, such as patents, less attention has been paid to unpatented innovation, about which there is naturally less publicly available information. Our study exploits disclosure on the fair value of acquired innovation to show that unpatented innovation plays an important, though often ignored, role in merger value creation. We detail the importance of unpatented technology and show that traditional approaches that rely only on R&D expenditures and patents lead to both misclassification of merger types and underestimates of the impact of innovation in value creation. Our evidence suggests that, on average, unpatented innovation accounts for a larger portion of synergies. We further show that higher (lower) gains accrue to the acquirer (the target) in relation to unpatented innovation, consistent with limited publicly available information about unpatented innovation reducing the target's bargaining power.
引用
收藏
页码:706 / 744
页数:39
相关论文
共 50 条
  • [21] Innovation and merger decisions in the pharmaceutical industry
    Morgan, EJ
    [J]. REVIEW OF INDUSTRIAL ORGANIZATION, 2001, 19 (02) : 181 - 197
  • [22] Financial innovation as facilitator of merger activity
    Hake, ER
    [J]. JOURNAL OF ECONOMIC ISSUES, 1998, 32 (01) : 145 - 170
  • [23] Innovation and Merger Decisions in the Pharmaceutical Industry
    Eleanor J. Morgan
    [J]. Review of Industrial Organization, 2001, 19 : 181 - 197
  • [24] INNOVATION CONSIDERATIONS IN HORIZONTAL MERGER CONTROL
    Kokkoris, Ioannis
    Valletti, Tommaso
    [J]. JOURNAL OF COMPETITION LAW & ECONOMICS, 2020, 16 (02) : 220 - 261
  • [25] Merger and Innovation Incentives in a Differentiated Industry
    Kesavayuth, Dusanee
    Lee, Sang-Ho
    Zikos, Vasileios
    [J]. INTERNATIONAL JOURNAL OF THE ECONOMICS OF BUSINESS, 2018, 25 (02) : 207 - 221
  • [26] Farm diversification through agritourism: innovation synergies
    Wu, Tsung-Chiung
    Chen, Chiu-Pin
    Hsu, Alex Yang-chan
    Wall, Geoffrey
    [J]. INTERNATIONAL FOOD AND AGRIBUSINESS MANAGEMENT REVIEW, 2024, 27 (03): : 509 - 525
  • [27] LICENSING UNPATENTED TECHNOLOGY
    BURSHTEIN, S
    [J]. FOOD AND DRUG LAW JOURNAL, 1988, 43 (04): : 637 - 640
  • [28] INNOVATION IN SMES: SYNERGIES OF INTERNAL AND EXTERNAL FACTORS
    Vassakis, Konstantinos
    Tsoukatos, Evangelos
    Lemonakis, Christos
    [J]. INNOVATION, ENTREPRENEURSHIP AND DIGITAL ECOSYSTEMS, 2016, : 2145 - 2146
  • [29] The Manufacture and Sale of Unpatented Parts
    Brown, Jo Baily
    [J]. JOURNAL OF THE PATENT OFFICE SOCIETY, 1936, 18 (09): : 573 - 603
  • [30] Denbury-Encore merger to test CO2-oil synergies
    不详
    [J]. OIL & GAS JOURNAL, 2009, 107 (42) : 26 - 27